Previous Close | 3.9500 |
Open | 3.9500 |
Bid | 3.9100 x 0 |
Ask | 3.9600 x 0 |
Day's Range | 3.9000 - 4.0500 |
52 Week Range | 2.1400 - 4.0700 |
Volume | |
Avg. Volume | 14,921 |
Market Cap | 98.807M |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | 2.71 |
EPS (TTM) | 1.4400 |
Earnings Date | Aug 09, 2023 - Aug 14, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.40 |
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three month period ended March 31, 2023.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the first quarter of 2023 on Thursday, May 11, 2023. The Company will also host a conference call on Friday, May 12, 2023 at 8:30am ET to discuss the results and corporate developments.
Mississauga, Ontario--(Newsfile Corp. - April 18, 2023) - Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre.Dates:Tuesday April 25, 2023 and Wednesday April 26, 2023Time:8:30 AM - 4:30 PM ETLocation: Metro Toronto Convention Centre,North
Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced its financial and operating results for the year ended December 31, 2022.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the three and twelve months ended December 31, 2022 after market close on March 16, 2023. The Company will also host a conference call on Friday, March 17, 2023 at 8:30am ET to discuss the results and corporate developments.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced completion and closing of a new credit facility (the "Credit Facility") with Royal Bank of Canada (RBC).
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
It might be of some concern to shareholders to see the Cipher Pharmaceuticals Inc. ( TSE:CPH ) share price down 12% in...
Cipher Pharmaceuticals Inc. (T.CPH) hit a new 52-week high of $3.97 Friday. No news stories available ...
The Planet MicroCap Showcase: VIRTUAL taking place on December 6-8, 2022, where 49 MicroCap public companies will be presenting virtually.
Cipher Pharmaceuticals (TSE:CPH) has had a great run on the share market with its stock up by a significant 30% over...
Cipher Pharmaceuticals ( TSE:CPH ) Third Quarter 2022 Results Key Financial Results Revenue: US$4.79m (up 6.2% from 3Q...
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and nine month periods ended September 30, 2022. Unless otherwise noted, all figures are in U.S. dollars.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q3 2022 financial results on Thursday, November 10, 2022 after market close. The company will hold a conference call on Friday, November 11, 2022 at 8:30am ET to discuss the results and corporate developments.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has accepted, notice of Cipher's intention to commence a normal course issuer bid ("NCIB") for its common shares (the "Common Shares").
Sigma Lithium Corporation (V.SGML) hit a new 52-week high of $37.76 Wednesday. No news stories available ...
Africa Oil Corp. (T.AOI) hit a new 52-week high of 38.5 cents Tuesday. Africa Oil will host a physical ...
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced the appointment of senior finance executive Bryan Jacobs as Chief Financial Officer ("CFO") effective August 15, 2022.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and six month periods ended June 30, 2022. Unless otherwise noted, all figures are in U.S. dollars.
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q2 2022 financial results on Thursday, August 11, 2022 after market close. The Company will also host a conference call on Friday, August 12, 2022 at 8:30am ET to discuss the results and corporate developments.
With its stock down 3.8% over the past three months, it is easy to disregard Cipher Pharmaceuticals (TSE:CPH). But if...
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") today announced that it held its annual and special meeting of shareholders earlier today and that all matters put forward before shareholders for consideration and approval as set out in the Company's management information circular dated May 13, 2022 were approved by the requisite majority of votes cast at the meeting. In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young L